Follow The Filings

ALHC Alignment Healthcare

Alignment Healthcare earnings company data as of 8:58 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ALHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALHC insider trades
  • $198K bought by 1 insider
  • $413M sold by 2 insiders outside a trading plan
  • $76.8M sold by 6 insiders under 10b5-1 plans
  1. John E Kao CEO
    Planned sale
    $356K 27,400 shares at $13.00 4.4% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  2. John E Kao CEO
    Planned sale
    $2.2M 172,600 shares at $12.96 22% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  3. Dawn Christine Maroney President
    Planned sale
    $70K 5,000 shares at $14.00 0.5% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  4. John E Kao CEO
    Planned sale
    $4.1M 298,000 shares at $13.88 27% of stake
    Traded Aug 10 Filed Aug 10
    ↗
  5. Dawn Christine Maroney President
    Planned sale
    $3.7M 177,068 shares at $20.83 16% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  6. John E Kao CEO
    Planned sale
    $5.9M 298,000 shares at $19.86 22% of stake
    Traded Jul 10 Filed Jul 14
    ↗
  7. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $600K 25,000 shares at $24.00 2.2% of stake
    Traded Jul 1 Filed Jul 1
    ↗
  8. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $575K 25,000 shares at $23.00 2.2% of stake
    Traded Jun 26 Filed Jun 26
    ↗
  9. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $550K 25,000 shares at $22.00 2.1% of stake
    Traded Jun 18 Filed Jun 18
    ↗
  10. Dawn Christine Maroney President
    Planned sale
    $586K 30,000 shares at $19.55 3.1% of stake
    Traded Jun 15 Filed Jun 15
    ↗
  11. Hyong Kim Chief Medical Officer
    Planned sale
    $714K 35,951 shares at $19.86 9.8% of stake
    Traded Jun 12 Filed Jun 15
    ↗
  12. Joseph S Konowiecki EVP, Corporate Affairs
    Planned sale
    $525K 25,000 shares at $21.00 2.1% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  13. John E Kao CEO
    Planned sale
    $6.1M 298,000 shares at $20.36 18% of stake
    Traded Jun 10 Filed Jun 12
    ↗
  14. Mark D. Kent President - MSO
    Buy
    $198K 14,848 shares at $13.31 New stake
    Traded Jun 2 Filed Jun 2
    ↗
  15. Dawn Christine Maroney President
    Planned sale
    $483K 30,000 shares at $16.09 2.9% of stake
    Traded May 15 Filed May 19
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 sales to cover taxes, 20 stock grants, 3 gifts, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 7.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.03,7.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.